Toronto - Delayed Quote CAD

Apotex Health Corp. (APTX.TO)

33.40 -0.27 (-0.80%)

At close: October 30 at 4:00:00 PM EDT

Apotex to Announce Second Quarter Fiscal 2027 Financial Results and Host Conference Call on November 12, 2026

CNW Group 24d ago

APTX.TO
-0.80%
APOTEX HEALTH CORP. ANNOUNCES CLOSING OF $1,250 MILLION INAUGURAL SENIOR UNSECURED NOTES OFFERING

CNW Group 27d ago

APTX.TO
-0.80%
APOTEX HEALTH CORP. ANNOUNCES $1,250 MILLION INAUGURAL SENIOR UNSECURED NOTES OFFERING

CNW Group 1mo ago

APTX.TO
-0.80%
APOTEX HEALTH CORP. ANNOUNCES CLOSING OF UPSIZED BOUGHT DEAL SECONDARY OFFERING

CNW Group 1mo ago

APTX.TO
-0.80%
Apotex Health (TSX:APTX) Stock Dropped, So What Is Driving Attention Now?

Simply Wall St. 1mo ago

APTX.TO
-0.80%
APOTEX HEALTH CORP. ANNOUNCES UPSIZE OF BOUGHT DEAL SECONDARY OFFERING TO $850 MILLION

CNW Group 1mo ago

APTX.TO
-0.80%
APOTEX HEALTH CORP. ANNOUNCES $750 MILLION BOUGHT DEAL SECONDARY OFFERING

CNW Group 1mo ago

APTX.TO
-0.80%
Cumberland Pharmaceuticals Inc (CPIX) (Q2 2026) Earnings Call Highlights: Strategic ...

GuruFocus.com 2mo ago

APTX.TO
-0.80%
CPIX
RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities

CNW Group 2mo ago

RDHL

APTX.TO
-0.80%
Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex

PR Newswire 3mo ago

CPIX

APTX.TO
-0.80%
Apotex first to receive Health Canada approval for SEVMIA™, a generic semaglutide for chronic weight management

CNW Group 4mo ago

APTX.TO
-0.80%
Apotex Health (TSX:APTX) Stock Valuation Check As P/E Premium Conflicts With DCF Discount

Simply Wall St. 4mo ago

APTX.NE

APTX.TO
-0.80%

U.S. markets open in 6h

Apotex Health Corp. (APTX.TO)

Apotex to Announce Second Quarter Fiscal 2027 Financial Results and Host Conference Call on November 12, 2026

APOTEX HEALTH CORP. ANNOUNCES CLOSING OF $1,250 MILLION INAUGURAL SENIOR UNSECURED NOTES OFFERING

APOTEX HEALTH CORP. ANNOUNCES $1,250 MILLION INAUGURAL SENIOR UNSECURED NOTES OFFERING

APOTEX HEALTH CORP. ANNOUNCES CLOSING OF UPSIZED BOUGHT DEAL SECONDARY OFFERING

Apotex Health (TSX:APTX) Stock Dropped, So What Is Driving Attention Now?

APOTEX HEALTH CORP. ANNOUNCES UPSIZE OF BOUGHT DEAL SECONDARY OFFERING TO $850 MILLION

APOTEX HEALTH CORP. ANNOUNCES $750 MILLION BOUGHT DEAL SECONDARY OFFERING

Cumberland Pharmaceuticals Inc (CPIX) (Q2 2026) Earnings Call Highlights: Strategic ...

RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities

Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex

Apotex first to receive Health Canada approval for SEVMIA™, a generic semaglutide for chronic weight management

Apotex Health (TSX:APTX) Stock Valuation Check As P/E Premium Conflicts With DCF Discount